107 related articles for article (PubMed ID: 38763020)
1. Optical biomarker analysis for renal cell carcinoma obtained from preoperative and postoperative patients using ATR-FTIR spectroscopy.
Tian Y; Fan X; Chen K; Chen X; Peng W; Wang L; Wang F
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Oct; 318():124426. PubMed ID: 38763020
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) Spectroscopy Discriminates the Elderly with a Low and High Percentage of Pathogenic CD4+ T Cells.
Praja RK; Wongwattanakul M; Tippayawat P; Phoksawat W; Jumnainsong A; Sornkayasit K; Leelayuwat C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159268
[TBL] [Abstract][Full Text] [Related]
5. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma.
Gatto F; Blum KA; Hosseini SS; Ghanaat M; Kashan M; Maccari F; Galeotti F; Hsieh JJ; Volpi N; Hakimi AA; Nielsen J
Eur Urol Oncol; 2018 Oct; 1(5):364-377. PubMed ID: 31158075
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of kidney injury molecule-1 in renal cell carcinoma.
Zhang KJ; Wilson GD; Kara S; Majeske A; Zhang PL; Hafron JM
Int Urol Nephrol; 2019 Nov; 51(11):1893-1902. PubMed ID: 31385177
[TBL] [Abstract][Full Text] [Related]
7. Value of urinary NMP-22 in patients with renal cell carcinoma.
Ozer G; Altinel M; Kocak B; Yazicioglu A; Gonenc F
Urology; 2002 Oct; 60(4):593-7. PubMed ID: 12385914
[TBL] [Abstract][Full Text] [Related]
8. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
[TBL] [Abstract][Full Text] [Related]
9. Attenuated Total Reflection Fourier Transform Infrared Spectroscopy combined with chemometric modelling for the classification of clinically relevant Enterococci.
Nitrosetein T; Wongwattanakul M; Chonanant C; Leelayuwat C; Charoensri N; Jearanaikoon P; Lulitanond A; Wood BR; Tippayawat P; Heraud P
J Appl Microbiol; 2021 Mar; 130(3):982-993. PubMed ID: 32780423
[TBL] [Abstract][Full Text] [Related]
10. MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma.
Raina P; Singh SK; Goswami AK; Kashyap MK; Khullar M; Sharma SK; Barwal KC
Mol Cell Biochem; 2022 Feb; 477(2):333-343. PubMed ID: 34716861
[TBL] [Abstract][Full Text] [Related]
11. Detection of Aflatoxin B1 in Peanut Oil Using Attenuated Total Reflection Fourier Transform Infrared Spectroscopy Combined with Partial Least Squares Discriminant Analysis and Support Vector Machine Models.
Song H; Li F; Guang P; Yang X; Pan H; Huang F
J Food Prot; 2021 Jul; 84(8):1315-1320. PubMed ID: 33710323
[TBL] [Abstract][Full Text] [Related]
12. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
[TBL] [Abstract][Full Text] [Related]
13. Detection of ovarian cancer (± neo-adjuvant chemotherapy effects) via ATR-FTIR spectroscopy: comparative analysis of blood and urine biofluids in a large patient cohort.
Giamougiannis P; Morais CLM; Rodriguez B; Wood NJ; Martin-Hirsch PL; Martin FL
Anal Bioanal Chem; 2021 Aug; 413(20):5095-5107. PubMed ID: 34195877
[TBL] [Abstract][Full Text] [Related]
14. Predictive model for recurrence of renal cell carcinoma by comparing pre- and postoperative urinary metabolite concentrations.
Morozumi K; Kawasaki Y; Maekawa M; Takasaki S; Sato T; Shimada S; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
Cancer Sci; 2022 Jan; 113(1):182-194. PubMed ID: 34710258
[TBL] [Abstract][Full Text] [Related]
15. Enhancing forensic investigations: Identifying bloodstains on various substrates through ATR-FTIR spectroscopy combined with machine learning algorithms.
Wei CT; You JL; Weng SK; Jian SY; Lee JC; Chiang TL
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Mar; 308():123755. PubMed ID: 38101254
[TBL] [Abstract][Full Text] [Related]
16. Textural differences between renal cell carcinoma subtypes: Machine learning-based quantitative computed tomography texture analysis with independent external validation.
Kocak B; Yardimci AH; Bektas CT; Turkcanoglu MH; Erdim C; Yucetas U; Koca SB; Kilickesmez O
Eur J Radiol; 2018 Oct; 107():149-157. PubMed ID: 30292260
[TBL] [Abstract][Full Text] [Related]
17. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
18. Fast screening using attenuated total reflectance- fourier transform infrared (ATR-FTIR) spectroscopy of patients based on D-dimer threshold value.
Brun BF; Nascimento MHC; Dias PAC; Marcarini WD; Singh MN; Filgueiras PR; Vassallo PF; Romão W; Mill JG; Martin FL; Barauna VG
Talanta; 2024 Mar; 269():125482. PubMed ID: 38042146
[TBL] [Abstract][Full Text] [Related]
19. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
[TBL] [Abstract][Full Text] [Related]
20. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
Frantzi M; Metzger J; Banks RE; Husi H; Klein J; Dakna M; Mullen W; Cartledge JJ; Schanstra JP; Brand K; Kuczyk MA; Mischak H; Vlahou A; Theodorescu D; Merseburger AS
J Proteomics; 2014 Feb; 98():44-58. PubMed ID: 24374379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
